Include repigmentation and depigmentation therapy:
- Repigmentation therapy when vitiligo involving <50 percent of the TBSA.
- Topical treatment: high-potency and mid-potency topical corticosteroids, topical calcineurin inhibitors, phototherapy: NB-UVB, PUVA, laser excimer 308nm, vitamin D analogs
- Systemic treatment: systemic corticosteroid, afamelanotide, janus kinase (JAK) inhibitor therapy, CD20 mab, statins, minnocycline, low dose cytokines and growth factors.
- Surgical therapies
- Depigmentation therapy when vitiligo involving >50 percent of the TBSA, for example: topical hydroquinone (monobenzone).